What is the ticker symbol for ProMIS Neurosciences?

ProMIS Neurosciences trades under the ticker PMN on NASDAQ.

What sector does ProMIS Neurosciences operate in?

ProMIS Neurosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PMN in a portfolio?

PortView shows PMN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

ProMIS Neurosciences (PMN) Stock Analysis

NASDAQHealthcareBiotechnology

$13.78+3.18%

1-year price historyRange $6.76 – $24.79

52-week range$13.78

$6.27$27.40

What ProMIS Neurosciences does

ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company leverages a unique computational discovery platform, utilizing its ProMIS and Collective Coordinates algorithms, to identify novel, disease-specific targets – known as epitopes – located on the surface of misfolded proteins. Its pipeline features several promising drug candidates, including PMN310, a monoclonal antibody designed to address toxic oligomers implicated in Alzheimer's disease. Another candidate, PMN267, targets superoxide dismutase 1 and TAR-DNA binding protein 43 in ALS, and alpha-synuclein associated with Parkinson's disease and Lewy body dementia. Finally, PMN442 is a monoclonal antibody aimed at toxic alpha-synuclein oligomers and seeding fibrils relevant to multiple system atrophy. Established in 2004, the company changed its name from Amorfix Life Sciences Ltd. to ProMIS Neurosciences, Inc. in July 2015. Its corporate headquarters are situated in Toronto, Canada.

Key metrics

Market cap

$18.01M

P/E (TTM)

-1.18

EPS (TTM)

$-11.66

Beta

-0.22

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$13.68

200-day avg

$12.38

52-week high

$27.40

52-week low

$6.27

CEO

Neil K. Warma

ETFs linked to PMN

Broad-market and Healthcare sector ETFs an investor holding ProMIS Neurosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PMN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PMN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for ProMIS Neurosciences?: ProMIS Neurosciences trades under the ticker PMN on NASDAQ.
Which exchange is PMN listed on?: PMN is listed on NASDAQ.
What sector does ProMIS Neurosciences operate in?: ProMIS Neurosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PMN in a portfolio?: PortView shows PMN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.